BRCA1 and cancer: Strong support for the idea that events originating outside the tissues that are at elevated cancer risk in BRCA1 mutation carriers are important drivers of such risk comes from the well-established association between menstrual cycle activity and incidence of serous carcinomas of the Müllerian tract.